These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


176 related items for PubMed ID: 6348806

  • 1. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN, Hoult JR.
    Pharmacology; 1983; 26(6):324-30. PubMed ID: 6348806
    [Abstract] [Full Text] [Related]

  • 2. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Metabolism of prostacyclin: formation of an active metabolite in the liver.
    Wong PY, Lee WH, Quilley CP, McGiff JC.
    Fed Proc; 1981 May 15; 40(7):2001-4. PubMed ID: 7014260
    [Abstract] [Full Text] [Related]

  • 5. Metabolism of prostacyclin by 9-hydroxyprostaglandin dehydrogenase in human platelets. Formation of a potent inhibitor of platelet aggregation and enzyme purification.
    Wong PY, Lee WH, Chao PH, Reiss RF, McGiff JC.
    J Biol Chem; 1980 Oct 10; 255(19):9021-4. PubMed ID: 6997309
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY, McGiff JC, Sun FF, Lee WH.
    Eur J Pharmacol; 1979 Dec 07; 60(2-3):245-8. PubMed ID: 393526
    [Abstract] [Full Text] [Related]

  • 8. Enzymatic inactivation of 6-keto-prostaglandin E1 in vitro: comparison with prostaglandin E1.
    Berry CN, Hoult JR, Griffiths RJ, Moore PK.
    Biochem Pharmacol; 1984 Apr 15; 33(8):1277-84. PubMed ID: 6549614
    [Abstract] [Full Text] [Related]

  • 9. Formation of 6-keto prostaglandin E1 in mammalian kidneys.
    Griffiths RJ, Moore PK.
    Br J Pharmacol; 1983 May 15; 79(1):149-55. PubMed ID: 6347300
    [Abstract] [Full Text] [Related]

  • 10. Synergism between PGE1-metabolites(13,14-dihydro-prostaglandin E1, 15-keto prostaglandin E1, 15-keto-13,14-dihydro-prostaglandin E1) and nitric oxide (NO) on platelet aggregation.
    Katzenschlager R, Weiss K, Rogatti W, Peskar BA, Sinzinger H.
    Prostaglandins Leukot Essent Fatty Acids; 1992 Mar 15; 45(3):207-10. PubMed ID: 1589447
    [Abstract] [Full Text] [Related]

  • 11. 6-keto PGE1: a possible metabolite of prostacyclin having platelet antiaggregatory effects.
    Quilley CP, McGiff JC, Lee WH, Sun FF, Wong PY.
    Hypertension; 1980 Mar 15; 2(4):524-8. PubMed ID: 6995292
    [Abstract] [Full Text] [Related]

  • 12. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
    Oliva D, Bernini F, Corsini A, Nicosia S.
    Biochem Pharmacol; 1984 Dec 01; 33(23):3755-8. PubMed ID: 6391491
    [Abstract] [Full Text] [Related]

  • 13. Assessment of the extent to exogenous prostaglandin I2 is converted to 6-keto-prostaglandin E1 in human subjects.
    Jackson EK, Goodman RP, Fitzgerald GA, Oates JA, Branch RA.
    J Pharmacol Exp Ther; 1982 Apr 01; 221(1):183-7. PubMed ID: 7038095
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
    Whittle BJ, Moncada S, Vane JR.
    Prostaglandins; 1978 Sep 01; 16(3):373-88. PubMed ID: 364545
    [Abstract] [Full Text] [Related]

  • 15. Catabolism of 6 keto PGE1: biological activation by the rat kidney in vitro.
    Moore PK, Griffiths RJ, Gaffen ZA.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):311-5. PubMed ID: 6684573
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Ascorbic acid enhances the formation of prostaglandin E1 in washed human platelets and prostacyclin in rat aortic rings.
    Srivastava KC.
    Prostaglandins Leukot Med; 1985 May 22; 18(2):227-33. PubMed ID: 3925463
    [Abstract] [Full Text] [Related]

  • 19. Biological activities of 6-keto-prostaglandin E1.
    Lewis R, Schölkens BA, Beck G.
    Prostaglandins Leukot Med; 1984 Dec 22; 16(3):303-24. PubMed ID: 6098901
    [Abstract] [Full Text] [Related]

  • 20. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL, Kadowitz PJ.
    J Pharmacol Exp Ther; 1980 Jun 22; 213(3):468-72. PubMed ID: 7193724
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.